| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 190.85B | 194.55B | 188.79B | 178.78B | 170.49B | 163.21B |
| Gross Profit | 84.18B | 85.70B | 83.55B | 76.55B | 76.02B | 74.91B |
| EBITDA | 19.44B | 20.45B | 20.82B | 14.89B | 18.33B | 19.35B |
| Net Income | 9.18B | 9.18B | 8.81B | 4.57B | 7.20B | 8.13B |
Balance Sheet | ||||||
| Total Assets | 196.26B | 210.29B | 203.32B | 202.09B | 197.52B | 198.06B |
| Cash, Cash Equivalents and Short-Term Investments | 18.54B | 30.69B | 26.08B | 26.63B | 38.07B | 53.96B |
| Total Debt | 212.00M | 3.00M | 227.00M | 923.00M | 1.11B | 1.54B |
| Total Liabilities | 46.25B | 51.99B | 51.77B | 47.62B | 45.75B | 47.02B |
| Stockholders Equity | 149.70B | 157.95B | 151.22B | 154.17B | 151.41B | 150.72B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.85B | 10.83B | 4.73B | 7.67B | 15.26B |
| Operating Cash Flow | 0.00 | 13.79B | 16.68B | 11.09B | 12.06B | 19.60B |
| Investing Cash Flow | 0.00 | -5.61B | -5.07B | -16.60B | -12.84B | -8.52B |
| Financing Cash Flow | 0.00 | -5.04B | -10.75B | -5.74B | -7.99B | -835.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥188.62B | 12.60 | ― | 3.41% | 3.85% | 41.80% | |
73 Outperform | ¥480.28B | 13.35 | 8.51% | 2.25% | 2.19% | 23.96% | |
73 Outperform | ¥32.01B | 9.06 | ― | 3.56% | 3.46% | 102.90% | |
73 Outperform | ¥167.70B | 11.62 | ― | 4.91% | 3.03% | 16.46% | |
72 Outperform | ¥191.02B | 21.16 | ― | 2.53% | 3.05% | 4.80% | |
67 Neutral | ¥18.74B | 8.52 | ― | 3.46% | 4.11% | 3.43% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |